Why Choose Aeroeclipse?

  • Breath actuated technology
  • Consistent respirable dose Virtually no drug is lost to the environment Protection from second-hand aerosols
  • Minimizes medication waste
  • Efficient treatment times
  • Biofeedback button confirms actuation and inhalation Reduced Length of Stay and Admission Rates through the ER1
  • Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC The AeroEclipse II Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient’s inspiratory flow.
  • This patient on-demand therapy means less medication waste, higher drug delivery efficiency, and safer clinician working environments. Combining the benefits of breath actuation and superior aerosol particle size, the
  • AeroEclipse delivers the industry’s most effective respirable dose. Supported by clinical evidence, the AeroEclipse provides approved dosing protocols throughout the hospital and for all patient populations.